A look at Braille labelling for pharmaceutical products. EC Directive 2004/27/CE requires Braille labelling and information to be provided with pharmaceutical products for human use, and EC firms are scrambling to implement it.
To bring a new product to market - and to maintain quality after the product's release - pharmaceutical companies must manage many factors for success.
A large generic pharmaceutical company wants to maximise ROI on R&D, but how?
A few years ago, two leading companies in a highly regulated industry were faced with the need to improve efficiency and reduce costs for a mission critical, but not differentiating, business process.